カテゴリー： QYResearch, 世界, 医療/バイオ

エステティックにおける併用療法のグローバル市場2023年：BTx-A/皮膚フィラー、BTx-A/レーザー、レーザー/外用薬、レーザー/高周波、皮膚フィラー/外用薬、その他

◆英語タイトル：Global Combination Therapies In Aesthetics Market Research Report 2023

QYResearchが発行した調査報告書（QYR23MA7446）◆商品コード：QYR23MA7446
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2023年3月
◆ページ数：93
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

本調査レポートは世界のエステティックにおける併用療法市場について調査・分析し、世界のエステティックにおける併用療法市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（BTx-A/皮膚フィラー、BTx-A/レーザー、レーザー/外用薬、レーザー/高周波、皮膚フィラー/外用薬、その他）、用途別セグメント分析（脱毛、タトゥー除去、スキンリサーフェシング、傷跡除去、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Alma Lasers Ltd.、Lumenis Ltd.、Cynosure Inc.、Valeant Pharmaceutical International, Inc.、Galderma S.A.、Anika Therapeutics, Inc.、Speciality European Pharma、Merz Pharma GmbH & Co. KGaA、Cutera, Inc、Allergan、Syneron Medical Ltdなどが含まれています。世界のエステティックにおける併用療法市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、エステティックにおける併用療法市場規模を推定する際に考慮しました。

・エステティックにおける併用療法市場の概要
- エステティックにおける併用療法のタイプ別セグメント
- 世界のエステティックにおける併用療法市場規模：タイプ別分析（BTx-A/皮膚フィラー、BTx-A/レーザー、レーザー/外用薬、レーザー/高周波、皮膚フィラー/外用薬、その他）
- エステティックにおける併用療法の用途別セグメント
- 世界のエステティックにおける併用療法市場規模：用途別分析（脱毛、タトゥー除去、スキンリサーフェシング、傷跡除去、その他）
- 世界のエステティックにおける併用療法市場規模予測（2018年-2029年）

・エステティックにおける併用療法市場の成長トレンド
- エステティックにおける併用療法の地域別市場規模（2018年-2029年）
- エステティックにおける併用療法市場ダイナミクス
- エステティックにおける併用療法の業界動向
- エステティックにおける併用療法市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・タイプ別セグメント：BTx-A/皮膚フィラー、BTx-A/レーザー、レーザー/外用薬、レーザー/高周波、皮膚フィラー/外用薬、その他
- 世界のエステティックにおける併用療法のタイプ別市場規模（2018年-2023年）
- 世界のエステティックにおける併用療法のタイプ別市場規模（2024年-2029年）

・用途別セグメント：脱毛、タトゥー除去、スキンリサーフェシング、傷跡除去、その他
- 世界のエステティックにおける併用療法の用途別市場規模（2018年-2023年）
- 世界のエステティックにおける併用療法の用途別市場規模（2024年-2029年）

・エステティックにおける併用療法の地域別市場規模
- 北米のエステティックにおける併用療法市場規模（2018年-2029年）
- アメリカのエステティックにおける併用療法市場規模（2018年-2029年）
- ヨーロッパのエステティックにおける併用療法市場規模（2018年-2029年）
- アジア太平洋のエステティックにおける併用療法市場規模（2018年-2029年）
- 中国のエステティックにおける併用療法市場規模（2018年-2029年）
- 日本のエステティックにおける併用療法市場規模（2018年-2029年）
- 韓国のエステティックにおける併用療法市場規模（2018年-2029年）
- インドのエステティックにおける併用療法市場規模（2018年-2029年）
- オーストラリアのエステティックにおける併用療法市場規模（2018年-2029年）
- 中南米のエステティックにおける併用療法市場規模（2018年-2029年）
- 中東・アフリカのエステティックにおける併用療法市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Alma Lasers Ltd.、Lumenis Ltd.、Cynosure Inc.、Valeant Pharmaceutical International, Inc.、Galderma S.A.、Anika Therapeutics, Inc.、Speciality European Pharma、Merz Pharma GmbH & Co. KGaA、Cutera, Inc、Allergan、Syneron Medical Ltd

・アナリストの観点/結論

・調査方法とデータソース

Aesthetics Combination Therapy Market Segmented By Hair Removal, Tattoo Removal, Skin Resurfacing, Scar Removal with BTx-A/Dermal Filler, BTx-A/Laser, Laser/Radiofrequency, Laser/Topical Drug, Dermal Filler/Topical Drug Therapy
Highlights
The global Combination Therapies In Aesthetics market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Combination Therapies In Aesthetics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Combination Therapies In Aesthetics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Combination Therapies In Aesthetics in Hair Removal is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Combination Therapies In Aesthetics include Alma Lasers Ltd., Lumenis Ltd., Cynosure Inc., Valeant Pharmaceutical International, Inc., Galderma S.A., Anika Therapeutics, Inc., Speciality European Pharma, Merz Pharma GmbH & Co. KGaA and Cutera, Inc, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Combination Therapies In Aesthetics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Combination Therapies In Aesthetics.
The Combination Therapies In Aesthetics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Combination Therapies In Aesthetics market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Combination Therapies In Aesthetics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Alma Lasers Ltd.
Lumenis Ltd.
Cynosure Inc.
Valeant Pharmaceutical International, Inc.
Galderma S.A.
Anika Therapeutics, Inc.
Speciality European Pharma
Merz Pharma GmbH & Co. KGaA
Cutera, Inc
Allergan
Syneron Medical Ltd
Segment by Type
BTx-A/Dermal Filler
BTx-A/Laser
Laser/Topical Drug
Laser/Radiofrequency
Dermal Filler/Topical Drug
Others
Segment by Application
Hair Removal
Tattoo Removal
Skin Resurfacing
Scar Removal
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Combination Therapies In Aesthetics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Combination Therapies In Aesthetics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 BTx-A/Dermal Filler
1.2.3 BTx-A/Laser
1.2.4 Laser/Topical Drug
1.2.5 Laser/Radiofrequency
1.2.6 Dermal Filler/Topical Drug
1.2.7 Others
1.3 Market by Application
1.3.1 Global Combination Therapies In Aesthetics Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hair Removal
1.3.3 Tattoo Removal
1.3.4 Skin Resurfacing
1.3.5 Scar Removal
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Combination Therapies In Aesthetics Market Perspective (2018-2029)
2.2 Combination Therapies In Aesthetics Growth Trends by Region
2.2.1 Global Combination Therapies In Aesthetics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Combination Therapies In Aesthetics Historic Market Size by Region (2018-2023)
2.2.3 Combination Therapies In Aesthetics Forecasted Market Size by Region (2024-2029)
2.3 Combination Therapies In Aesthetics Market Dynamics
2.3.1 Combination Therapies In Aesthetics Industry Trends
2.3.2 Combination Therapies In Aesthetics Market Drivers
2.3.3 Combination Therapies In Aesthetics Market Challenges
2.3.4 Combination Therapies In Aesthetics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Combination Therapies In Aesthetics Players by Revenue
3.1.1 Global Top Combination Therapies In Aesthetics Players by Revenue (2018-2023)
3.1.2 Global Combination Therapies In Aesthetics Revenue Market Share by Players (2018-2023)
3.2 Global Combination Therapies In Aesthetics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Combination Therapies In Aesthetics Revenue
3.4 Global Combination Therapies In Aesthetics Market Concentration Ratio
3.4.1 Global Combination Therapies In Aesthetics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Combination Therapies In Aesthetics Revenue in 2022
3.5 Combination Therapies In Aesthetics Key Players Head office and Area Served
3.6 Key Players Combination Therapies In Aesthetics Product Solution and Service
3.7 Date of Enter into Combination Therapies In Aesthetics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Combination Therapies In Aesthetics Breakdown Data by Type
4.1 Global Combination Therapies In Aesthetics Historic Market Size by Type (2018-2023)
4.2 Global Combination Therapies In Aesthetics Forecasted Market Size by Type (2024-2029)
5 Combination Therapies In Aesthetics Breakdown Data by Application
5.1 Global Combination Therapies In Aesthetics Historic Market Size by Application (2018-2023)
5.2 Global Combination Therapies In Aesthetics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Combination Therapies In Aesthetics Market Size (2018-2029)
6.2 North America Combination Therapies In Aesthetics Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Combination Therapies In Aesthetics Market Size by Country (2018-2023)
6.4 North America Combination Therapies In Aesthetics Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Combination Therapies In Aesthetics Market Size (2018-2029)
7.2 Europe Combination Therapies In Aesthetics Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Combination Therapies In Aesthetics Market Size by Country (2018-2023)
7.4 Europe Combination Therapies In Aesthetics Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Combination Therapies In Aesthetics Market Size (2018-2029)
8.2 Asia-Pacific Combination Therapies In Aesthetics Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Combination Therapies In Aesthetics Market Size by Region (2018-2023)
8.4 Asia-Pacific Combination Therapies In Aesthetics Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Combination Therapies In Aesthetics Market Size (2018-2029)
9.2 Latin America Combination Therapies In Aesthetics Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Combination Therapies In Aesthetics Market Size by Country (2018-2023)
9.4 Latin America Combination Therapies In Aesthetics Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Combination Therapies In Aesthetics Market Size (2018-2029)
10.2 Middle East & Africa Combination Therapies In Aesthetics Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Combination Therapies In Aesthetics Market Size by Country (2018-2023)
10.4 Middle East & Africa Combination Therapies In Aesthetics Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Alma Lasers Ltd.
11.1.1 Alma Lasers Ltd. Company Detail
11.1.2 Alma Lasers Ltd. Business Overview
11.1.3 Alma Lasers Ltd. Combination Therapies In Aesthetics Introduction
11.1.4 Alma Lasers Ltd. Revenue in Combination Therapies In Aesthetics Business (2018-2023)
11.1.5 Alma Lasers Ltd. Recent Development
11.2 Lumenis Ltd.
11.2.1 Lumenis Ltd. Company Detail
11.2.2 Lumenis Ltd. Business Overview
11.2.3 Lumenis Ltd. Combination Therapies In Aesthetics Introduction
11.2.4 Lumenis Ltd. Revenue in Combination Therapies In Aesthetics Business (2018-2023)
11.2.5 Lumenis Ltd. Recent Development
11.3 Cynosure Inc.
11.3.1 Cynosure Inc. Company Detail
11.3.2 Cynosure Inc. Business Overview
11.3.3 Cynosure Inc. Combination Therapies In Aesthetics Introduction
11.3.4 Cynosure Inc. Revenue in Combination Therapies In Aesthetics Business (2018-2023)
11.3.5 Cynosure Inc. Recent Development
11.4 Valeant Pharmaceutical International, Inc.
11.4.1 Valeant Pharmaceutical International, Inc. Company Detail
11.4.2 Valeant Pharmaceutical International, Inc. Business Overview
11.4.3 Valeant Pharmaceutical International, Inc. Combination Therapies In Aesthetics Introduction
11.4.4 Valeant Pharmaceutical International, Inc. Revenue in Combination Therapies In Aesthetics Business (2018-2023)
11.4.5 Valeant Pharmaceutical International, Inc. Recent Development
11.5 Galderma S.A.
11.5.1 Galderma S.A. Company Detail
11.5.2 Galderma S.A. Business Overview
11.5.3 Galderma S.A. Combination Therapies In Aesthetics Introduction
11.5.4 Galderma S.A. Revenue in Combination Therapies In Aesthetics Business (2018-2023)
11.5.5 Galderma S.A. Recent Development
11.6 Anika Therapeutics, Inc.
11.6.1 Anika Therapeutics, Inc. Company Detail
11.6.2 Anika Therapeutics, Inc. Business Overview
11.6.3 Anika Therapeutics, Inc. Combination Therapies In Aesthetics Introduction
11.6.4 Anika Therapeutics, Inc. Revenue in Combination Therapies In Aesthetics Business (2018-2023)
11.6.5 Anika Therapeutics, Inc. Recent Development
11.7 Speciality European Pharma
11.7.1 Speciality European Pharma Company Detail
11.7.2 Speciality European Pharma Business Overview
11.7.3 Speciality European Pharma Combination Therapies In Aesthetics Introduction
11.7.4 Speciality European Pharma Revenue in Combination Therapies In Aesthetics Business (2018-2023)
11.7.5 Speciality European Pharma Recent Development
11.8 Merz Pharma GmbH & Co. KGaA
11.8.1 Merz Pharma GmbH & Co. KGaA Company Detail
11.8.2 Merz Pharma GmbH & Co. KGaA Business Overview
11.8.3 Merz Pharma GmbH & Co. KGaA Combination Therapies In Aesthetics Introduction
11.8.4 Merz Pharma GmbH & Co. KGaA Revenue in Combination Therapies In Aesthetics Business (2018-2023)
11.8.5 Merz Pharma GmbH & Co. KGaA Recent Development
11.9 Cutera, Inc
11.9.1 Cutera, Inc Company Detail
11.9.2 Cutera, Inc Business Overview
11.9.3 Cutera, Inc Combination Therapies In Aesthetics Introduction
11.9.4 Cutera, Inc Revenue in Combination Therapies In Aesthetics Business (2018-2023)
11.9.5 Cutera, Inc Recent Development
11.10 Allergan
11.10.1 Allergan Company Detail
11.10.2 Allergan Business Overview
11.10.3 Allergan Combination Therapies In Aesthetics Introduction
11.10.4 Allergan Revenue in Combination Therapies In Aesthetics Business (2018-2023)
11.10.5 Allergan Recent Development
11.11 Syneron Medical Ltd
11.11.1 Syneron Medical Ltd Company Detail
11.11.2 Syneron Medical Ltd Business Overview
11.11.3 Syneron Medical Ltd Combination Therapies In Aesthetics Introduction
11.11.4 Syneron Medical Ltd Revenue in Combination Therapies In Aesthetics Business (2018-2023)
11.11.5 Syneron Medical Ltd Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ エステティックにおける併用療法のグローバル市場2023年：BTx-A/皮膚フィラー、BTx-A/レーザー、レーザー/外用薬、レーザー/高周波、皮膚フィラー/外用薬、その他(Global Combination Therapies In Aesthetics Market Research Report 2023)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • マイクロLED物質移動のグローバル市場2023年：静電吸着、液状集合体転写、エラストマープリントフィルム転写、レーザー
  • アンチセンスオリゴヌクレオチド療法の世界市場見通し2023年-2029年
  • エステティックにおける併用療法の世界市場見通し2023年-2029年
  • 世界のレーザーがん治療市場インサイト及び予測（二酸化炭素（CO2）レーザー、アルゴンレーザー、イットリウムアルミニウムガーネット（Nd：YAG）レーザー）
  • 世界の3次元フォトリソグラフィ装置市場インサイト及び予測（紫外線（UV）レーザー、極端紫外線（Extreme Ultraviolet）レーザー）